WC&P International
 
Home  |  Archive  |  Links  |  Media Kit  |  About WCP  |  Contact WCP  |  Glossary  |  Videos

SUBSCRIBE  |  BUYER'S GUIDE  |  CALENDAR  |  PRODUCT TRADE SHOW  |  HISTORY PROJECT  |  CLASSIFIEDS

Current IssueOctober 24, 2014
Registered users login here to see extended content.
 
July 2003: Volume 45, Number 7

Nosocomial? Waterborne Routes of Hospital-Acquired Infections
by Kelly A. Reynolds, MSPH, Ph.D.

0703OnTap.rtf

Nosocomial? Waterborne Routes of Hospital-Acquired Infections Kelly A. Reynolds, MSPH, Ph.D.

In the United States, microbiological organisms are common to tap water meeting the highest treatment and regulatory standards. While some of these organisms may be harmful to healthy individuals, others are considered acceptable “normal flora” of general water supplies but may cause serious disease in severely immunocompromised persons. Hospitals serve food and water to some of the most susceptible populations to chronic and deadly infections. Conservatively, it’s estimated one in 10 hospitalized patients will contract an infection from the hospital environment itself. These acquired infections are termed “nosocomial” and are a great concern to health care providers.

Microbes of concern
A wide variety of viral, protozoan and bacterial organisms are “frank” waterborne pathogens—found in fecally contaminated water—and capable of causing waterborne disease in the general population (i.e, hepatitis A, Cryptosporidium or Salmonella). The goal of municipal water treatment, in part, is to minimize the presence of these microbial organisms via filtration and disinfection methodologies. Several bacteria, however, are naturally present in the aquatic environment and soil and are commonly present in drinking water supplies (i.e., Legionella species, Aeromonas species, Pseudomonas aeruginosa, and Mycobacterium avium complex—see Table 1).

These organisms are typically opportunistic pathogens and may be present in low numbers in drinking water but survive and grow within the distribution system, biofilms and storage tanks. Opportunistic pathogens aren’t considered harmful to most individuals, only causing disease in immunocompromised hosts (i.e., the very young, elderly and those with chronic infections or prior illnesses) and often only in severely ill hosts. Opportunistic pathogens responsible for the majority of nosocomial infections are primarily transmitted via contaminated medical devices, aerosolization or contaminated hands and surfaces. Rarely are these organisms transmitted via the gastrointestinal tract from actually drinking the water.

Who’s at risk?
Scanning literature from January 1966 to December 2001, researchers found >2 million nosocomial infections occur in up to 10 percent of patients each year in the United States. Many infections lead to a substantial level of illness, death and financial burden, and are known to occur via the waterborne route. In fact, an estimated 1,400 U.S. deaths each year are the result of waterborne hospital-acquired pneumonia caused by Pseudomonas aeruginosa alone.1 Numerous studies have documented hospital water supplies as the source of nosocomial infections in patients. What’s most disturbing is the fact these infections are largely preventable.

Assessing individual risk is important in determining the best preventative approach to minimizing waterborne nosocomial disease. Two presenters2 at the NSF International/World Health Organization symposium on HPC Bacteria in Drinking Water in Geneva in April 2002 provided a description of various levels of immunosuppression and respective protection measures related to drinking water quality. A summary of the results of their working group, “Hygienic measures in immunocompro-mised patients,” is listed below:

Protection level I:
Mild immunosuppression

• Acute or chronic leukemia, malignant lymphoma, childhood histiocystosis X under maintenance therapy without neutropenia
• Solid tumors (within six months of chemotherapy)
• Long-term corticosteroid therapy with <20 milligrams per day (mg/d) prednisone or equivalent
• Autologous stem cell transplantation (within six months of discharge)
Action: Avoid any circumstances with elevated infection risks (i.e., drinking water from uncontrolled sources).

Protection level II:
Moderate immunosuppression

• Acute or chronic leukemia, malignant lymphoma, childhood histiocystosis
• Solid tumors under intensive treatment
• Long-term corticosteroid therapy with >20 mg/d prednisone or equivalent
• Solid organ transplantation under intensive treatment phase
Action: Drinking water should have low bacterial count. Bathroom installations should be controlled for bacterial reservoirs.

Protection level III:
Severe immunosuppression

• Acute or chronic leukemia, malignant lymphoma, childhood histiocystosis
• Solid tumors under intensive treatment
• Solid organ transplantation under intensive treatment phase (induction or rejection therapy)
• Allogenic stem cell transplantation (first six-12 months after engraftment)
Action: Drinking water should have a very low bacterial count (use water filters/controlled sparkling water). Strict control of bathroom installations and water for showering (to be avoided if no control possible).

Protection level IV:
Extreme immunosuppression

• Allogenic stem cell transplantation (until engraftment)
Action: Only sterile fluids for drinking, mouth care, and washing allowed.

While the preceding descriptions offer a starting point for control of nosocomial disease transmission via a waterborne route, specific categories preclude many susceptible individuals. For example, the general population is relatively resistant to Legionella infection; however, in addition to hospital patients, people with chronic health conditions (i.e., chronic obstructive pulmonary disease, diabetes, heavy smokers and drinkers) may also be affected by exposure to Legionella. Therefore, an individual assessment of risk is critical to determine feasible and necessary protective limits.

Patients may be exposed to harmful waterborne organisms via bathing, showering and drinking water. In addition, hands and medical equipment washed or rinsed in tap water are known to be a source of transmission. For some organisms, i.e., Cryptosporidium, even small concentrations can have a significant impact on the exposed population. Consider that a level of one Cryptosporidium oocyst per 1,000 liters (L) of drinking water is enough to cause 6,000 infections per year in a city the size of New York.1 For most opportunistic pathogens, large numbers of bacteria are required to become problematic.

Most nosocomial waterborne infections are a result of aerosolization or open wound infection of opportunistic pathogens, not the gastrointestinal route. Even in cases of systemic immune deficiency, the protective status of the gastrointestinal tract is often intact.

An ounce of prevention
Most parents can probably recall being advised to carefully sterilize all formula, bottles and other oral-contact items of newborn babies. While these efforts require a certain level of commitment and diligence, they were achievable and provided an added level of safety and confidence. A similar effort, however, isn’t necessarily available or recognized for members of the population that may be at equal or even greater risk of waterborne disease than infants, the medically compromised.

Although standards and regulations exist for control and prevention of water contamination in community water supplies, no specific regulations exist for protection of special populations from waterborne nosocomial infections. A major concern in the drinking water industry is the ability of opportunistic pathogens to proliferate in the distribution system, biofilms and some point-of-use water treatment devices. A four-step approach to prevention of nosocomial waterborne infections is recommended:1

1. Reduce exposure—Minimize all immunocompromised patient’s exposure to tap water, regardless of documented presence of opportunistic organisms. This simple measure of control has proven effective for reducing the level of legionellosis, cryptosporidiosis and other nosocomial waterborne infections. Drinking water should be purchased sterile or boiled for three minutes. Distillation is also effective. Showers should be replaced with sponge baths.

2. Education of staff and patients—Implementation of existing infection control measures, i.e., hand sterilization, equipment sterilization and aseptic techniques.

3. Targeted surveillance—Monitoring infection rates of nosocomial illnesses and contamination levels of water system supplies.

4. Other measures—Heat treatment of water, i.e., maintain hot water at >60°C (although risk of scalding increases). Establish a maintenance schedule to repair and disinfect contaminated water systems at hospital sites including storage tanks, distribution lines, and filtration systems.

Public health agencies have issued several advisories to immunocompromised populations. For example, following a large outbreak of Cryptosporidium, the U.S. Environmental Protection Agency and the Centers for Disease Control and Prevention (CDC) issued guidelines for prevention of waterborne protozoan infections in the immuno-compromised. The recommendations stated the immunocompromised should only consume water that’s bottled sterile, submicron filtered or boiled.

Furthermore, the CDC recommends hospital water supply systems are routinely maintained and a sterile water source be considered for immunocompromised populations. The CDC also recommends high-risk patients minimize exposure to activities that may aerosolize harmful microorganisms. The CDC targeted stem cell transplant patients, suggesting use of sterile water for drinking, hygiene practices and rinsing medical treatment devices. These patients are encouraged to forego showering and exposure to faucet water.

Conclusion
The production of sterile drinking water for the majority of the population isn’t only unfeasible but also unnecessary. Most individuals are capable of resisting infection from ubiquitous, opportunistic organisms found throughout the environment and known to regrow in distribution systems or certain water treatment devices. For those with severely compromised immune systems, however, current water quality guidelines don’t provide adequate health protection and defensive action is recommended in accordance with the level of individual immunosuppression. Additional research is needed to evaluate current protective measures and development of new strategies.

Municipal tap water supplies, limited by conditions of water stagnation and biofilm build-up in distribution pipelines, fail to meet water quality needs of hospital wards serving severely immunocompromised patients. The best methods of control include the use of sterile water for high-risk populations, treated at the point-of-use. Effective and low-cost water sterilization methods (i.e., boiling for three minutes) are readily available in this country and have proven effective for preventing nosocomial waterborne infections.

References
1. Anaissie, E.J., et al., “Hospital water supply as a source of nosocomial infections: a plea for action,” Archives of Internal Medicine, 162: 1483-1492, 2002.

2. Glasmacher, A., and S. Engelhart, “Protection of immunocompromised patients from waterborne infections,” Presented at the NSF International/ WHO symposium on HPC Bacteria in Drinking Water, Geneva, Switzerland, April 22-24, 2002.

3. Rusin, P.A., et al., “Risk assessment of opportunistic bacterial pathogens in drinking water,” Reviews in Environmental Contamination Toxicology, 152: 57-83, 1997.

About the author
Dr. Kelly A. Reynolds is a research scientist at the University of Arizona with a focus on development of rapid methods for detecting human pathogenic viruses in drinking water. She holds a master of science degree in public health (MSPH) from the University of South Florida and doctorate in microbiology from the University of Arizona. Reynolds has also been a member of the WC&P Technical Review Committee since 1997.



Table 1: Some common opportunistic pathogens found in drinking water

………………………..Prevalence………………Disease
…………………………in drinking……………manifestation/…………………………………Other
Organism………………water*………………infection route………………………………comments
-------------------------------------------------------------------------------------------
Pseudomonas……Up to 24%……Urinary tract, wound and skin infections,…… Estimated to account
aeruginosa………………………………burn victims, pneumonia, respiratory tract…………for 10-20% of
…………………………………………………… infections in cystic fibrosis patients………..nosocomial infections
…………………………………………………………………………………………………………………-- Highly resistant
……………………………………………………………………………………………………………………to disinfectants.

Aeromonas………Up to 27%……Wound infections, septicemia, and diarrhea…….Widely distributed hydrophila……………………………………………………………………………………………………in the environment.

Mycobacterium……Up to 70%……Respiratory, intestinal and generalized……2nd most common
spp………………………………………………infection in HIV patients. Rarely……………cause of death in
………………………………………………..documented pulmonary disease in………………HIV-positive patients
…………………………………………………immunocompetent hosts

Acinetobacter……Up to 38%……Bloodstream infections, pneumonia, bacteremia.
calcoaceticus

Flavobacterium……Traced to……Neonatal meningitis, adult septicemia.
meningosepticum…water
……………………………sources

Legionella spp…….Up to 33%……Pontiac fever, Legionnaire’s Disease, ……Aerosol route -- Isolated
………………………………………………….respiratory infection……………………………………in drinking water
…………………………………………………………………………………………………………………samples. Frequently
…………………………………………………………………………………………………………………colonize in water
…………………………………………………………………………………………………………………distribution systems

###